04:47 PM EDT, 05/06/2024 (MT Newswires) -- Jeffrey Robert Ajer, Executive Vice President, Chief Commercial Officer, on May 02, 2024, sold 5,000 shares in Biomarin Pharmaceutical ( BMRN ) for $414,550. Following the Form 4 filing with the SEC, Ajer has control over a total of 66,767 shares of the company, with 66,767 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048477/000104847724000073/xslF345X03/wk-form4_1715028037.xml